Saving money is wise, but investing is profitable
In accordance with the legislation of the Czech Republic, the Company provides services only to qualified investors!

Akoya Biosciences (AKYA) FINANCIAL RESULTS FOR THE FOURTH QUARTER 2021.

15.03.2022

Non-GAAP net loss per share for the fourth quarter of 2021 was $-0.47.  
 
Revenue was $16.20million, up 25.5% from the same period last year.